期刊文献+

晚期肺癌患者肺部感染死亡危险因素分析 被引量:19

Risk Factors for Death of Advanced Lung Cancer Patients with Lung Infection
下载PDF
导出
摘要 目的分析肺癌伴肺部感染患者死亡的相关危险因素。方法回顾2010年1月—2017年5月收治的186例晚期肺癌患者临床资料,其中肺部感染死亡者52例,并收集肺部感染死亡的相关危险因素。结果晚期肺癌患者肺部感染死亡率为27.96%(52/186)。在诸多因素中,年龄(P=0.039)、BMI值(P=0.000)、组织分化程度低(P=0.003)、功能状态评分(P=0.022)、转移部位≥3(P=0.029)、合并症(P=0.034)、多重耐药菌感染(P=0.000)、血红蛋白浓度<90 g/L(P=0.014)等在死亡组和非死亡组之间差异具有统计学意义。结论年龄(≥60岁)、BMI值(<20 kg/m2)、组织分化程度(低)、抗肿瘤治疗药物(≥3种)、靶向药物治疗、转移部位(≥3)、合并症、多重耐药菌感染、血红蛋白浓度(<90 g/L)等是晚期肺癌患者肺部感染死亡的主要危险因素。 Objective To analyze the risk factors of death in lung cancer patients with pulmonary infection. Methods From January 2010 to May 2017, 186 advanced lung cancer patients were treated, among which 52 patients with pulmonary infection died. Risk factors for the death of pulmonary infection were collected. Results The mortality rate of lung infection in advanced lung cancer patients was 27.96%(52/186). The differences of age(P=0.039), BMI value(P=0.000), low degree of differentiation(P=0.003), functional status score(P=0.022), ≥3 metastatic sites(P=0.029), complications(P=0.034), multiple resistant bacteria infection(P=0.000), hemoglobin concentration 90 g/L(P=0.014) between the death group and survival group were statistically significant. Conclusion Age(≥60 years old), BMI value(20 kg/m^2), histological grade(low), anti-tumour drugs treatment(≥3 regimens), targeted drug therapy, metastatic sites(≥3), complications, multiple resistant bacteria infection, hemoglobin concentration(90 g/L) are the main risk factors for the death of advanced cancer patients with pulmonary infection.
作者 谢朝云 覃家露 熊芸 刘良 韦华 XIE Zhaoyun;Q;XIONG Yun;LIU Liang;WEI Hua(Management of Hospital Infection, The Third Affiliated Hospital of Guizhou Medical University, Duyun 558000, China;Department of Oncology, The Third Affiliated Hospital of Guizhou Medical University, Duyun 558000, China;Department of Respiratory Medicine, The Third Affiliated Hospital of Guizhou Medical University, Duyun 558000, China)
出处 《肿瘤防治研究》 CAS CSCD 2018年第4期221-224,共4页 Cancer Research on Prevention and Treatment
基金 贵州省科技厅联合项目(黔科合LH字[2014]7162号) 贵州省黔南州社会发展科技项目(黔南科合社字[2013]20号)
关键词 肺癌 肺部感染 死亡 危险因素 LOGISTIC回归分析 Lung cancer Lung infection Death Risk factors Logistic regression analysis
  • 相关文献

参考文献10

二级参考文献63

  • 1洪永青,朱蓉,孟自力.机械通气下纤维支气管镜介入诊治重症肺部感染的临床观察[J].中国呼吸与危重监护杂志,2011,10(3):237-240. 被引量:63
  • 2罗彬,于湘友,姜华,尹微.纤维支气管镜吸痰联合肺泡灌洗在呼吸机相关性肺炎治疗中的应用[J].中国老年学杂志,2014,34(10):2656-2658. 被引量:69
  • 3游捷,施志明.肺癌国际生存质量量表与体能状态评定指标及中医症状量表的关系[J].中国中西医结合杂志,2005,25(7):595-599. 被引量:57
  • 4中华医学会呼吸病学会.医院获得性肺炎的诊断和治疗指南.中国临床医生,2001,29(3):27-29.
  • 5Caras I, Grigorescu A, Stavaru C, et al. Evidence for immunedefects in breast and lung cancer patients [J].Cancer hnmunol Immunother, 2004, 53 ( 12 ) : 1146-1152.
  • 6Gao Y, Tang W, Dai X, et al. Effects of water-soluble ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer [ J ] . J Med Food, 2005, 8 ( 2 ) : 159-168.
  • 7Dancewicz M, Szymankiewicz M, Bella M, et al. Bronchial bacterial colonization in patients with lung cancer [J].. Pneumonol Alergol Pol, 2009, 77 ( 3 ) : 242-247.
  • 8Ziglam HM, Gelly K, Olver W. A survey of the management of neutropenic fever in oncology units in the UK [J]. Int J Antimicrob Agents, 2007, 29 (4) : 430-433.
  • 9Aguilar-guisado M, Espigado I, Cordero E, et al. Empirical antifungal therapy in selected patients with persistent febrile neutropenia [J] . Bone Marrow Transplant, 2010, 45 (1): 159-164.
  • 10Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts [ J ] . Clin Infect Dis, 2007, 44 ( 3 ) : 402-409.

共引文献6154

同被引文献169

引证文献19

二级引证文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部